Literature DB >> 17172401

Spindle checkpoint function and cellular sensitivity to antimitotic drugs.

Hiroshi Y Yamada1, Gary J Gorbsky.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17172401      PMCID： PMC2596631          DOI： 10.1158/1535-7163.MCT-06-0319

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN： 1535-7163            Impact factor:   6.261


× No keyword cloud information.
  57 in total

1.  Differential mitotic responses to microtubule-stabilizing and -destabilizing drugs.

Authors:  Jie-Guang Chen; Susan Band Horwitz
Journal:  Cancer Res       Date:  2002-04-01       Impact factor: 12.701

2.  The Schizosaccharomyces pombe spindle checkpoint protein mad2p blocks anaphase and genetically interacts with the anaphase-promoting complex.

Authors:  X He; T E Patterson; S Sazer
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

3.  The mitotic spindle checkpoint is a critical determinant for topoisomerase-based chemotherapy.

Authors:  Celia Vogel; Anne Kienitz; Rolf Müller; Holger Bastians
Journal:  J Biol Chem       Date:  2004-12-16       Impact factor: 5.157

4.  Growth-inhibiting effects of taxol on human liver cancer in vitro and in nude mice.

Authors:  Jin-Hui Yuan; Ru-Ping Zhang; Ru-Gang Zhang; Li-Xia Guo; Xing-Wang Wang; Dan Luo; Yong Xie; Hong Xie
Journal:  World J Gastroenterol       Date:  2000-04       Impact factor: 5.742

5.  Tetraploidy and tumor development.

Authors:  Robert L Margolis
Journal:  Cancer Cell       Date:  2005-11       Impact factor: 31.743

6.  Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells.

Authors:  Loren Michel; Elena Diaz-Rodriguez; Gopeshwar Narayan; Eva Hernando; Vundavalli V V S Murty; Robert Benezra
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

7.  Caspase 3, periodically expressed and activated at G2/M transition, is required for nocodazole-induced mitotic checkpoint.

Authors:  S-L Hsu; C-T R Yu; S-C Yin; M-J Tang; A-C Tien; Y-M Wu; C-Y F Huang
Journal:  Apoptosis       Date:  2006-05       Impact factor: 4.677

8.  Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint.

Authors:  Tamotsu Sudo; Masayuki Nitta; Hideyuki Saya; Naoto T Ueno
Journal:  Cancer Res       Date:  2004-04-01       Impact factor: 12.701

9.  Additive effects of radiation and docetaxel on murine SCCVII tumors in vivo: special reference to changes in the cell cycle.

Authors:  Minoru Suzuki; Kiyoshi Nakamatsu; Shuichi Kanamori; Shin-Ichiro Masunaga; Yasumasa Nishimura
Journal:  Radiat Res       Date:  2003-06       Impact factor: 2.841

10.  MAD2-induced sensitization to vincristine is associated with mitotic arrest and Raf/Bcl-2 phosphorylation in nasopharyngeal carcinoma cells.

Authors:  Xianghong Wang; Dong-Yan Jin; Hing Lok Wong; Huichen Feng; Yong-Chuan Wong; Sai Wah Tsao
Journal:  Oncogene       Date:  2003-01-09       Impact factor: 9.867
View more
  37 in total

1.  A biosensor-based approach reveals links between efflux pump expression and cell cycle regulation in pleiotropic drug resistance of yeast.

Authors:  Jian Li; Kristen Kolberg; Ulrich Schlecht; Robert P St Onge; Ana Maria Aparicio; Joe Horecka; Ronald W Davis; Maureen E Hillenmeyer; Colin J B Harvey
Journal:  J Biol Chem       Date:  2018-12-04       Impact factor: 5.157

Review 2.  Fine tuning chemotherapy to match BRCA1 status.

Authors:  Melissa Price; Alvaro N A Monteiro
Journal:  Biochem Pharmacol       Date:  2010-05-25       Impact factor: 5.858

3.  Up-regulation of the mitotic checkpoint component Mad1 causes chromosomal instability and resistance to microtubule poisons.

Authors:  Sean D Ryan; Eric M C Britigan; Lauren M Zasadil; Kristen Witte; Anjon Audhya; Avtar Roopra; Beth A Weaver
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-09       Impact factor: 11.205

Review 4.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

5.  Mitotic Exit Dysfunction through the Deregulation of APC/C Characterizes Cisplatin-Resistant State in Epithelial Ovarian Cancer.

Authors:  Anil Belur Nagaraj; Olga Kovalenko; Rita Avelar; Peronne Joseph; Annalyn Brown; Arshia Surti; Sandra Mantilla; Analisa DiFeo
Journal:  Clin Cancer Res       Date:  2018-04-13       Impact factor: 12.531

Review 6.  Mitotic checkpoint defects: en route to cancer and drug resistance.

Authors:  Sinjini Sarkar; Pranab Kumar Sahoo; Sutapa Mahata; Ranita Pal; Dipanwita Ghosh; Tanuma Mistry; Sushmita Ghosh; Tanmoy Bera; Vilas D Nasare
Journal:  Chromosome Res       Date:  2021-01-06       Impact factor: 5.239

7.  Unliganded progesterone receptors attenuate taxane-induced breast cancer cell death by modulating the spindle assembly checkpoint.

Authors:  Melanie M Badtke; Purevsuren Jambal; Wendy W Dye; Monique A Spillman; Miriam D Post; Kathryn B Horwitz; Britta M Jacobsen
Journal:  Breast Cancer Res Treat       Date:  2011-02-22       Impact factor: 4.872

8.  Targeting PLK1 overcomes T-DM1 resistance via CDK1-dependent phosphorylation and inactivation of Bcl-2/xL in HER2-positive breast cancer.

Authors:  Özge Saatci; Simone Borgoni; Özge Akbulut; Selvi Durmuş; Umar Raza; Erol Eyüpoğlu; Can Alkan; Aytekin Akyol; Özgür Kütük; Stefan Wiemann; Özgür Şahin
Journal:  Oncogene       Date:  2018-02-02       Impact factor: 9.867

9.  Cell Cycle-Dependent Mechanisms Underlie Vincristine-Induced Death of Primary Acute Lymphoblastic Leukemia Cells.

Authors:  Anisha Kothari; Walter N Hittelman; Timothy C Chambers
Journal:  Cancer Res       Date:  2016-05-06       Impact factor: 12.701

10.  Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells.

Authors:  Shizuko Sei; Jodie K Mussio; Quan-en Yang; Kunio Nagashima; Ralph E Parchment; Matthew C Coffey; Robert H Shoemaker; Joseph E Tomaszewski
Journal:  Mol Cancer       Date:  2009-07-14       Impact factor: 27.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.